BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25619630)

  • 1. Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.
    Mir MA; Kochuparambil ST; Abraham RS; Rodriguez V; Howard M; Hsu AP; Jackson AE; Holland SM; Patnaik MM
    Cancer Med; 2015 Apr; 4(4):490-9. PubMed ID: 25619630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
    Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
    Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature.
    Kazenwadel J; Secker GA; Liu YJ; Rosenfeld JA; Wildin RS; Cuellar-Rodriguez J; Hsu AP; Dyack S; Fernandez CV; Chong CE; Babic M; Bardy PG; Shimamura A; Zhang MY; Walsh T; Holland SM; Hickstein DD; Horwitz MS; Hahn CN; Scott HS; Harvey NL
    Blood; 2012 Feb; 119(5):1283-91. PubMed ID: 22147895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
    Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
    Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GATA2 gene mutations: 3 cases].
    Perrard N; Pokeerbux MR; Quesnel B; Duployez N; Fenwarth L; Preudhomme C; Lefèvre G; Baillet C; Launay D; Terriou L
    Rev Med Interne; 2022 Nov; 43(11):677-682. PubMed ID: 36041908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with Bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline GATA2 Mutations.
    Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
    Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation.
    Sakata N; Okano M; Masako R; Tanaka A; Yamashita Y; Karasuno T; Imadome KI; Okada M; Sugimoto K
    Int J Hematol; 2021 Feb; 113(2):290-296. PubMed ID: 32865708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.
    Pasquet M; Bellanné-Chantelot C; Tavitian S; Prade N; Beaupain B; Larochelle O; Petit A; Rohrlich P; Ferrand C; Van Den Neste E; Poirel HA; Lamy T; Ouachée-Chardin M; Mansat-De Mas V; Corre J; Récher C; Plat G; Bachelerie F; Donadieu J; Delabesse E
    Blood; 2013 Jan; 121(5):822-9. PubMed ID: 23223431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.
    Lübking A; Vosberg S; Konstandin NP; Dufour A; Graf A; Krebs S; Blum H; Weber A; Lenhoff S; Ehinger M; Spiekermann K; Greif PA; Cammenga J
    Leuk Res Rep; 2015; 4(2):72-5. PubMed ID: 26716079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/GATA2 haploinsufficiency.
    Koegel AK; Hofmann I; Moffitt K; Degar B; Duncan C; Tubman VN
    Pediatr Blood Cancer; 2016 Oct; 63(10):1844-7. PubMed ID: 27232273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA2 germline mutations impair GATA2 transcription, causing haploinsufficiency: functional analysis of the p.Arg396Gln mutation.
    Cortés-Lavaud X; Landecho MF; Maicas M; Urquiza L; Merino J; Moreno-Miralles I; Odero MD
    J Immunol; 2015 Mar; 194(5):2190-8. PubMed ID: 25624456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature.
    Mallhi K; Dix DB; Niederhoffer KY; Armstrong L; Rozmus J
    Pediatr Transplant; 2016 Nov; 20(7):1004-1007. PubMed ID: 27416790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized verrucosis in a patient with GATA2 deficiency.
    West ES; Kingsbery MY; Mintz EM; Hsu AP; Holland SM; Rady PL; Tyring SK; Grossman ME
    Br J Dermatol; 2014 May; 170(5):1182-6. PubMed ID: 24359037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literature.
    Gao J; Gentzler RD; Timms AE; Horwitz MS; Frankfurt O; Altman JK; Peterson LC
    J Hematol Oncol; 2014 Apr; 7():36. PubMed ID: 24754962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatologic manifestations of the "MonoMAC" syndrome. a systematic review.
    Johnson JA; Yu SS; Elist M; Arkfeld D; Panush RS
    Clin Rheumatol; 2015 Sep; 34(9):1643-5. PubMed ID: 25739845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
    Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
    Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.